AstraZeneca PLC
AZN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $6 | $6 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $8 | $9 | $8 |
| Inventory | $5 | $5 | $5 | $9 |
| Other Curr. Assets | $4 | $5 | $2 | $3 |
| Total Curr. Assets | $26 | $25 | $23 | $26 |
| Property Plant & Equip (Net) | $12 | $11 | $9 | $10 |
| Goodwill | $21 | $20 | $20 | $20 |
| Intangibles | $37 | $38 | $39 | $42 |
| Long-Term Investments | $0 | $2 | $0 | $0 |
| Tax Assets | $5 | $0 | $3 | $4 |
| Other NC Assets | $3 | $6 | $2 | $2 |
| Total NC Assets | $78 | $76 | $74 | $79 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $104 | $101 | $96 | $105 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $3 |
| Short-Term Debt | $2 | $5 | $5 | $2 |
| Tax Payable | $2 | $2 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $20 | $20 | $17 | $17 |
| Total Curr. Liab. | $28 | $31 | $26 | $23 |
| LT Debt | $28 | $23 | $24 | $29 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $0 | $3 | $6 |
| Other NC Liab. | $4 | $8 | $6 | $8 |
| Total NC Liab. | $35 | $31 | $33 | $43 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $63 | $62 | $59 | $66 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $3 | $5 | -$1 | $2 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $37 | $33 | $37 | $37 |
| Total Equity | $41 | $39 | $37 | $39 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $104 | $101 | $96 | $105 |
| Net Debt | $25 | $23 | $23 | $24 |